According to the latest report by IMARC Group, titled “Neurosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global neurosurgery devices market exhibited moderate growth during 2015-2020. Neurosurgery devices are used for performing and treating pathologies in the central and peripheral nervous systems. They are mainly utilized for diagnosing, preventing, and treating neurological disorders and conditions like epilepsy and traumatic brain, depression, and spinal cord injuries. They also aid in conducting discectomies, microsurgeries and adjusting the skull bone during surgeries.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Neurosurgery Devices Market Trends:
The increasing incidences of neurological disorders, especially among the geriatric population, represents one of the key factors augmenting the market growth. Besides this, the growing awareness among the masses about the available effective treatments are also contributing to the growth of the market. Moreover, the leading manufacturers are introducing technological advancements, including the development of innovative minimally invasive (MI) equipment like liquid embolic and clot retrieval devices, flow diversion, balloon catheters and neuroendovascular stents. This, in confluence with improvements in the healthcare infrastructure and extensive research and development (R&D) activities, is positively influencing the market. On account of these factors, IMARC Group expects the global neurosurgery devices market to grow at a CAGR of 8% during the forecast period (2021-2026).
- Based on the product type, the market has been divided into neurointerventional devices, neurostimulation devices, neurosurgical navigation systems, cerebral spinal fluid (CSF) management devices and others.
- On the basis of the application, the market has been segmented into spinal cord stimulation (chronic pain, failed back surgery syndrome and ischemia), deep brain stimulation (Parkinson’s disease, tremor, depression and others) and neuroendoscopy (transnasal, intraventricular and transcranial).
- Based on the end user, the market has been classified into hospitals, ambulatory surgical centers, and others.
- Region-wise, the market has been segregated into North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (the United Kingdom, Germany, France, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Abbott Laboratories, Ackermann Instrumente GmbH, Adeor Medical AG, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, DePuy Synthes Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Nevro Corp, Nihon Kohden Corporation, Penumbra Inc., and Stryker Corporation.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800